194 related articles for article (PubMed ID: 38291496)
21. Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma.
Jiang S; Dong Y; Wang J; Zhang X; Liu W; Wei Y; Zhou H; Shen L; Yang J; Zhu Q
Front Immunol; 2023; 14():1207061. PubMed ID: 37662929
[TBL] [Abstract][Full Text] [Related]
22. Identification and Verification of Tumor Immune Microenvironment-Related Prognostic Genes in Kidney Renal Clear Cell Carcinoma.
Kong G; Wang Y; Huang Y; Shi Z
Biomed Res Int; 2022; 2022():5563668. PubMed ID: 35127943
[TBL] [Abstract][Full Text] [Related]
23. Construction of an endoplasmic reticulum stress-related gene model for predicting prognosis and immune features in kidney renal clear cell carcinoma.
Shen Y; Cao Y; Zhou L; Wu J; Mao M
Front Mol Biosci; 2022; 9():928006. PubMed ID: 36120545
[No Abstract] [Full Text] [Related]
24. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
Zhong S; Chen S; Lin H; Luo Y; He J
BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
[TBL] [Abstract][Full Text] [Related]
25. Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma.
Sun X; Liu P
Front Oncol; 2023; 13():1073941. PubMed ID: 36816967
[TBL] [Abstract][Full Text] [Related]
26. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
[TBL] [Abstract][Full Text] [Related]
27. Construction and validation of risk model of EMT-related prognostic genes for kidney renal clear cell carcinoma.
Wu LL; Yuan SF; Lin QY; Chen GM; Zhang W; Zheng WE; Lin HL
J Gene Med; 2023 Nov; 25(11):e3549. PubMed ID: 37271571
[TBL] [Abstract][Full Text] [Related]
28. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
Front Immunol; 2022; 13():954440. PubMed ID: 36059510
[TBL] [Abstract][Full Text] [Related]
29. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412
[No Abstract] [Full Text] [Related]
30. Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration.
Yao Y; Chen H; Lou M; Chen T
Front Genet; 2023; 14():1071694. PubMed ID: 36755576
[No Abstract] [Full Text] [Related]
31. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
32. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
[TBL] [Abstract][Full Text] [Related]
33. Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma.
Cai C; Shu K; Chen W; Ding J; Guo Z; Wei Y; Zhang W
Aging (Albany NY); 2023 Jun; 15(12):5304-5338. PubMed ID: 37379129
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a kidney renal clear cell carcinoma prognostic model relying on pyroptosis-related LncRNAs-A multidimensional comprehensive bioinformatics exploration.
Liu C; Dai S; Geng H; Jiang Z; Teng X; Liu K; Tuo Z; Peng L; Yang C; Bi L
Eur J Med Res; 2023 Sep; 28(1):341. PubMed ID: 37700389
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive analysis of essential meiotic endonuclease 1 to prognosis and immune infiltration in kidney renal clear cell carcinoma.
Li HD; Ma HX; Ma JH; Kong SP; Zhao ST; Fan SQ; Qin F; Ma JG
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):584-602. PubMed ID: 38305603
[TBL] [Abstract][Full Text] [Related]
36. Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing.
Sun J; Zhang X; Wu F; Zhu B; Xie H
BMC Urol; 2024 Apr; 24(1):84. PubMed ID: 38600527
[TBL] [Abstract][Full Text] [Related]
37. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
[TBL] [Abstract][Full Text] [Related]
38. Exploring the role of coagulation-related genes in renal cell carcinoma: Implications for tumor microenvironment and prognostic biomarkers.
Qiu Y; Liao Y; Zhang J; Ye Y; Zhang Z; Jiang Z; Zhang J; Xin J; Lv S; Peng H
Comput Biol Chem; 2024 Jun; 110():108082. PubMed ID: 38663187
[TBL] [Abstract][Full Text] [Related]
39. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK
Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148
[TBL] [Abstract][Full Text] [Related]
40. Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma.
Cai Z; He Y; Yu Z; Hu J; Xiao Z; Zu X; Li Z; Li H
Front Immunol; 2022; 13():933241. PubMed ID: 36211378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
